Literature DB >> 16720653

Comparison of follicle-stimulating-hormone-stimulated dimeric inhibin and estradiol responses as indicators of granulosa cell function in polycystic ovary syndrome and normal women.

Deborah S Wachs1, Mickey S Coffler, Pamela J Malcom, R Jeffrey Chang.   

Abstract

CONTEXT: Follicular phase secretion of inhibin B, like that of estradiol (E(2)), correlates with the quantity and quality of developing follicles. However, it has not been established whether inhibin B responses to gonadotropin stimulation parallel those of E(2) as a reflection of granulosa cell functional capacity.
OBJECTIVE: Our objective was to determine whether inhibin B responses to FSH stimulation are similar to those of E(2) in women with polycystic ovary syndrome (PCOS) and normal women. DESIGN AND
SETTING: We conducted a prospective study to compare ovarian responses in two groups of women at a general clinical research center in a tertiary academic medical center. PATIENTS: Women with PCOS, 18-35 yr (n = 19), and normal ovulatory controls, 18-35 yr (n = 7), were recruited for study.
INTERVENTIONS: Serum samples were measured over a 24-h period after an iv injection of recombinant human FSH, 150 IU. MAIN OUTCOME MEASURES: Serum E(2), inhibin A, and inhibin B responses after FSH administration were assessed.
RESULTS: In PCOS women, the 24-h production of inhibin B and E(2) after FSH was significantly greater than that of normal controls. Within the PCOS group, the fold change in inhibin B was significantly greater than that of E(2). Inhibin A responses between groups were similar and of markedly lower magnitude.
CONCLUSIONS: FSH-stimulated inhibin B responses may be employed to assess the functional capacity of granulosa cells in PCOS and normal women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720653     DOI: 10.1210/jc.2006-0442

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.

Authors:  Annie A Guedikian; Alexandria Y Lee; Tristan R Grogan; David H Abbott; Karla Largaespada; Gregorio D Chazenbalk; Daniel A Dumesic
Journal:  Fertil Steril       Date:  2018-02-07       Impact factor: 7.329

2.  Single-cell expression analysis of BMP15 and GDF9 in mature oocytes and BMPR2 in cumulus cells of women with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation.

Authors:  Luciana Ochuiuto Teixeira de Resende; Alessandra Aparecida Vireque; Laura Ferreira Santana; Daniel Antunes Moreno; Ana Carolina Japur de Sá Rosa e Silva; Rui Alberto Ferriani; Carlos Alberto Scrideli; Rosana Maria Reis
Journal:  J Assist Reprod Genet       Date:  2012-07-24       Impact factor: 3.412

3.  The impact of polycystic ovary syndrome and body mass index on the absorption of recombinant human follicle stimulating hormone.

Authors:  Malinda S Lee; Andrea Lanes; Andrey V Dolinko; Alexandra Bailin; Elizabeth Ginsburg
Journal:  J Assist Reprod Genet       Date:  2020-07-04       Impact factor: 3.412

Review 4.  Disordered follicle development.

Authors:  R Jeffrey Chang; Heidi Cook-Andersen
Journal:  Mol Cell Endocrinol       Date:  2012-07-31       Impact factor: 4.102

5.  Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome.

Authors:  Deborah S Wachs; Mickey S Coffler; Pamela J Malcom; Shunichi Shimasaki; R Jeffrey Chang
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

6.  Comparison of inhibin B and estradiol responses to intravenous FSH in women with polycystic ovary syndrome and normal women.

Authors:  Marcus A Rosencrantz; Deborah S Wachs; Mickey S Coffler; Pamela J Malcom; Michael Donohue; R Jeffrey Chang
Journal:  Hum Reprod       Date:  2009-10-22       Impact factor: 6.918

7.  Characterization of functionally typical and atypical types of polycystic ovary syndrome.

Authors:  Jennifer Hirshfeld-Cytron; Randall B Barnes; David A Ehrmann; Anthony Caruso; Monica M Mortensen; Robert L Rosenfield
Journal:  J Clin Endocrinol Metab       Date:  2009-02-24       Impact factor: 5.958

8.  Decreased inhibin B responses following recombinant human chorionic gonadotropin administration in normal women and women with polycystic ovary syndrome.

Authors:  Rana F Shayya; Marcus A Rosencrantz; Sandy S Chuan; Heidi Cook-Andersen; William E Roudebush; H Irene Su; Shunichi Shimasaki; R Jeffrey Chang
Journal:  Fertil Steril       Date:  2013-11-01       Impact factor: 7.329

9.  Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone.

Authors:  Konstantinos Dafopoulos; Christos Venetis; Christina I Messini; Spyros Pournaras; George Anifandis; Antonios Garas; Ioannis E Messinis
Journal:  Reprod Biol Endocrinol       Date:  2011-04-29       Impact factor: 5.211

Review 10.  Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction.

Authors:  Julia Johansson; Elisabet Stener-Victorin
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-02       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.